NOVO.B.DK

320.05

+3.38%↑

GMAB.DK

2,048

+3.07%↑

HLUNB.DK

43.48

-1.5%↓

ZEAL.DK

517

+1.25%↑

NOVO.B.DK

320.05

+3.38%↑

GMAB.DK

2,048

+3.07%↑

HLUNB.DK

43.48

-1.5%↓

ZEAL.DK

517

+1.25%↑

NOVO.B.DK

320.05

+3.38%↑

GMAB.DK

2,048

+3.07%↑

HLUNB.DK

43.48

-1.5%↓

ZEAL.DK

517

+1.25%↑

NOVO.B.DK

320.05

+3.38%↑

GMAB.DK

2,048

+3.07%↑

HLUNB.DK

43.48

-1.5%↓

ZEAL.DK

517

+1.25%↑

NOVO.B.DK

320.05

+3.38%↑

GMAB.DK

2,048

+3.07%↑

HLUNB.DK

43.48

-1.5%↓

ZEAL.DK

517

+1.25%↑

Search

Coloplast A-S (Class B)

Închisă

565.2 0.53

Rezumat

Modificarea prețului

24h

Curent

Minim

555.6

Maxim

567.6

Indicatori cheie

By Trading Economics

Venit

-107M

805M

Vânzări

28M

7B

P/E

Medie Sector

34.765

77.671

EPS

3.88

Randament dividend

3.96

Marjă de profit

11.569

Angajați

16,744

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.96%

2.35%

Statistici piață

By TradingEconomics

Capitalizare de piață

-10B

127B

Deschiderea anterioară

564.67

Închiderea anterioară

565.2

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 dec. 2025, 22:02 UTC

Câștiguri

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 dec. 2025, 21:46 UTC

Câștiguri

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 dec. 2025, 23:52 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 dec. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 dec. 2025, 23:20 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 dec. 2025, 23:15 UTC

Câștiguri

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 dec. 2025, 22:59 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 dec. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 dec. 2025, 22:40 UTC

Câștiguri

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec. 2025, 22:06 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 22:06 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec. 2025, 22:02 UTC

Câștiguri

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec. 2025, 22:00 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 dec. 2025, 21:53 UTC

Câștiguri

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec. 2025, 21:50 UTC

Achiziții, Fuziuni, Preluări

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 dec. 2025, 21:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

10 dec. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 dec. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 dec. 2025, 21:45 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 21:33 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 dec. 2025, 21:32 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 dec. 2025, 21:25 UTC

Câștiguri

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 dec. 2025, 21:16 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 dec. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 dec. 2025, 21:15 UTC

Câștiguri

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 dec. 2025, 21:14 UTC

Câștiguri

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 dec. 2025, 21:14 UTC

Câștiguri

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat